187(top 1%)
papers
10.8K(top 1%)
citations
29(top 1%)
h-index
101(top 1%)
g-index
190
all documents
11.5K
doc citations
1.6K
citing journals
172
times ranked

Top Articles

#TitleJournalYearCitations
1Preoperative assessment of liver function: a comparison of 99mTc-Mebrofenin scintigraphy with indocyanine green clearance testLiver International20047,546
2Management of Hepatocellular Carcinoma in Japan: JSH Consensus Statements and Recommendations 2021 UpdateLiver Cancer2021307
3Validation and Potential of Albumin-Bilirubin Grade and Prognostication in a Nationwide Survey of 46,681 Hepatocellular Carcinoma Patients in Japan: The Need for a More Detailed Evaluation of Hepatic FunctionLiver Cancer2017202
4Usefulness of albumin–bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinomaJournal of Gastroenterology and Hepatology (Australia)2016198
5Albumin-Bilirubin (ALBI) Grade as Part of the Evidence-Based Clinical Practice Guideline for HCC of the Japan Society of Hepatology: A Comparison with the Liver Damage and Child-Pugh ClassificationsLiver Cancer2017159
6Validation of Modified ALBI Grade for More Detailed Assessment of Hepatic Function in Hepatocellular Carcinoma Patients: A Multicenter AnalysisLiver Cancer2019159
7Prognostic factor of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions—Multicenter analysisCancer Medicine2019131
8Hepatic Function during Repeated TACE Procedures and Prognosis after Introducing Sorafenib in Patients with Unresectable Hepatocellular Carcinoma: Multicenter AnalysisDigestive Diseases2017113
9Clinical features of lenvatinib for unresectable hepatocellular carcinoma in real‐world conditions: Multicenter analysisCancer Medicine2019112
10Muscle atrophy as pre-sarcopenia in Japanese patients with chronic liver disease: computed tomography is useful for evaluationJournal of Gastroenterology201590
11Newly Proposed ALBI Grade and ALBI-T Score as Tools for Assessment of Hepatic Function and Prognosis in Hepatocellular Carcinoma PatientsLiver Cancer201988
12Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenibHepatology Research201782
13Therapeutic potential of lenvatinib for unresectable hepatocellular carcinoma in clinical practice: Multicenter analysisHepatology Research201981
14Important Clinical Factors in Sequential Therapy Including Lenvatinib against Unresectable Hepatocellular CarcinomaOncology201966
15Neutrophil‐to‐lymphocyte ratio is associated with survival in patients with unresectable hepatocellular carcinoma treated with lenvatinibLiver International202051
16Daclatasvir and asunaprevir in hemodialysis patients with hepatitis C virus infection: a nationwide retrospective study in JapanJournal of Gastroenterology201849
17Lenvatinib versus sorafenib in first‐line treatment of unresectable hepatocellular carcinoma: An inverse probability of treatment weighting analysisLiver International202145
18Safety and efficacy of lenvatinib in elderly patients with unresectable hepatocellular carcinoma: A multicenter analysis with propensity score matchingHepatology Research202044
19Atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma: Early clinical experienceCancer Reports202243
20LBA36 Final analysis of RATIONALE-301: Randomized, phase III study of tislelizumab versus sorafenib as first-line treatment for unresectable hepatocellular carcinomaAnnals of Oncology202243
21Colonic Intussusception Caused by Anisakiasis: A Case Report and Review of the LiteratureInternal Medicine201342
22Role of hepatic resection in patients with intermediate‐stage hepatocellular carcinoma: A multicenter study from JapanCancer Science201740
23Impact of albumin–bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time‐dependent receiver operating characteristicJournal of Gastroenterology and Hepatology (Australia)201940
24Early Relative Change in Hepatic Function with Lenvatinib for Unresectable Hepatocellular CarcinomaOncology201939
25Proposed New Sub-Grouping for Intermediate-Stage Hepatocellular Carcinoma Using Albumin-Bilirubin GradeOncology201636
26EZ-ALBI Score for Predicting Hepatocellular Carcinoma PrognosisLiver Cancer202035
27Prognostic impact of C-reactive protein and alpha-fetoprotein in immunotherapy score in hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a multicenter retrospective studyHepatology International202235
28Effect of direct oral anticoagulants on the risk of delayed bleeding after gastric endoscopic submucosal dissectionDigestive Endoscopy201734
29Early Changes in Circulating FGF19 and Ang-2 Levels as Possible Predictive Biomarkers of Clinical Response to Lenvatinib Therapy in Hepatocellular CarcinomaCancers202034
30Lenvatinib versus Sorafenib as first‐line treatment in hepatocellular carcinoma: A multi‐institutional matched case‐control studyHepatology Research202133
31Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial ChemoembolizationOncology201531
32Prognosis and therapy for ruptured hepatocellular carcinoma: Problems with staging and treatment strategyEuropean Journal of Radiology201531
33ALBI Score as a Novel Tool in Staging and Treatment Planning for Hepatocellular Carcinoma: Advantage of ALBI Grade for Universal Assessment of Hepatic FunctionLiver Cancer201730
34Transcatheter Arterial Chemoembolization With or Without Radiofrequency Ablation: Outcomes in Patients With Barcelona Clinic Liver Cancer Stage B Hepatocellular CarcinomaAmerican Journal of Roentgenology201830
35Efficacy of lenvatinib for unresectable hepatocellular carcinoma based on background liver disease etiology: multi-center retrospective studyScientific Reports202130
36Prediction of Prognosis of Intermediate-Stage HCC Patients: Validation of the Tumor Marker Score in a Nationwide Database in JapanLiver Cancer201928
37Clinical importance of muscle volume in lenvatinib treatment for hepatocellular carcinoma: Analysis adjusted with inverse probability weightingJournal of Gastroenterology and Hepatology (Australia)202128
38Neutrophil–lymphocyte ratio predicts early outcomes in patients with unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab: a multicenter analysisEuropean Journal of Gastroenterology and Hepatology202227
39Efficacy and safety of elbasvir/grazoprevir for Japanese patients with genotype 1b chronic hepatitis C complicated by chronic kidney disease, including those undergoing hemodialysis: A post hoc analysis of a multicenter studyJournal of Gastroenterology and Hepatology (Australia)201926
40Real-world virological efficacy and safety of elbasvir and grazoprevir in patients with chronic hepatitis C virus genotype 1 infection in JapanJournal of Gastroenterology201825
41Using ALBI score at the start of sorafenib treatment to predict regorafenib treatment candidates in patients with hepatocellular carcinomaJapanese Journal of Clinical Oncology201925
42The effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients with refractory factors in the real world: a comprehensive analysis of a prospective multicenter studyHepatology International202025
43Direct-acting antivirals improve survival and recurrence rates after treatment of hepatocellular carcinoma within the Milan criteriaJournal of Gastroenterology202125
44Nonalcoholic steatohepatitis in hepatocarcinoma: new insights about its prognostic role in patients treated with lenvatinibESMO Open202125
45Early experience of atezolizumab plus bevacizumab treatment for unresectable hepatocellular carcinoma BCLC‐B stage patients classified as beyond up to seven criteria – Multicenter analysisHepatology Research202225
46Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma CasesOncology201724
47Nutritional Index as Prognostic Indicator in Patients Receiving Lenvatinib Treatment for Unresectable Hepatocellular CarcinomaOncology202024
48Easy surveillance of muscle volume decline in chronic liver disease patients using finger‐circle (yubi‐wakka) testJournal of Cachexia, Sarcopenia and Muscle201923
49Real‐world experience of 12‐week direct‐acting antiviral regimen of glecaprevir and pibrentasvir in patients with chronic hepatitis C virus infectionJournal of Gastroenterology and Hepatology (Australia)202023
50Huge Pancreatic Acinar Cell Carcinoma with High Levels of AFP and Fucosylated AFP (AFP-L3)Internal Medicine201222